Related Experiment Video
Updated: Jul 9, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)
M Gallicchio1, A C Rosa, C Dianzani
1Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Torino, Italy. margherita.gallicchio@unito.it
Background And Purpose:
We investigated the ability of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, to modulate expression of ICAM-1 and VCAM-1 in the colon cancer cell line HT29.
Experimental Approach:
We analysed the effect of celecoxib on ICAM-1 and VCAM-1 protein and mRNA expression in HT29 cells. Experiments were performed in the presence of mitogen-activated protein kinases (MAPK) inhibitors to evaluate the involvement of these kinases in this phenomenon. We evaluated adhesion of HT29 cells to FCS-coated plastic wells in the presence of celecoxib or MAPK inhibitors. Furthermore, we studied the effect of celecoxib on apoptosis.
Key Results:
Celecoxib down-regulated ICAM-1 and VCAM-1 expression in HT29 cells in a time- and dose-dependent way. Celecoxib reduced activation of p38 and p55 c-Jun terminal NH(2) kinase (JNK) MAPKs, but did not affect p46 JNK or p42/44 MAPK phosphorylation. Pretreatment with SB202190 or SP600125, specific inhibitors of p38 and JNK MAPKs, respectively, reduced ICAM-1 and VCAM-1 expression in HT29 cells dose-dependently. Adhesion of HT29 cells to FCS-coated plastic wells was inhibited dose-dependently by celecoxib, and also by SB202190 and SP600125. Celecoxib showed a pro-apoptotic effect, inducing Bax and BID but down-regulating Bcl-2.
Conclusions And Implications:
Our findings show that celecoxib caused down-regulation of ICAM-1 and VCAM-1, affecting the adhesive properties of HT29 cells in a COX-2 independent way, inhibiting p38 and p55 MAPKs and activating a pro-apoptotic pathway.
Insights
Celecoxib reduces ICAM-1 and VCAM-1 expression in colon cancer cells, impacting cell adhesion. This occurs independently of COX-2, by inhibiting p38 and JNK pathways and promoting apoptosis.
Area of Science:
- Molecular biology
- Cancer research
- Pharmacology
Background:
- Intercellular adhesion molecules (ICAM-1, VCAM-1) play roles in cancer progression.
- Selective cyclooxygenase-2 (COX-2) inhibitors, like celecoxib, are used in cancer treatment.
- Understanding celecoxib's effects on adhesion molecules is crucial for cancer therapy.
Purpose of the Study:
- To investigate celecoxib's effect on ICAM-1 and VCAM-1 expression in HT29 colon cancer cells.
- To explore the role of mitogen-activated protein kinases (MAPKs) in celecoxib's action.
- To assess celecoxib's impact on HT29 cell adhesion and apoptosis.
Main Methods:
- Celecoxib treatment of HT29 cells to measure ICAM-1 and VCAM-1 protein and mRNA levels.
- Use of specific MAPK inhibitors (SB202190, SP600125) to assess pathway involvement.
- Evaluation of HT29 cell adhesion to coated surfaces and apoptosis markers (Bax, BID, Bcl-2).
Main Results:
- Celecoxib dose- and time-dependently downregulated ICAM-1 and VCAM-1 expression.
- Celecoxib inhibited p38 and JNK (p55) MAPK activation, but not p46 JNK or p42/44 MAPK.
- Inhibition of p38 and JNK pathways mimicked celecoxib's effect on ICAM-1/VCAM-1 and cell adhesion; celecoxib induced apoptosis.
Conclusions:
- Celecoxib downregulates ICAM-1 and VCAM-1 in HT29 cells via a COX-2 independent mechanism.
- The effect involves the inhibition of p38 and p55 JNK MAPKs, influencing cell adhesion.
- Celecoxib activates a pro-apoptotic pathway, suggesting potential therapeutic applications.
More Related Videos
06:31Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cancer Cell Migration through Invadopodia
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...